{"prompt": "['2016N277425_00', 'CONFIDENTIAL', '2018N377698_00', '201749', 'Moderate: An event that is sufficiently discomforting to interfere with normal', 'everyday activities', 'Severe: An event that prevents normal everyday activities. - an AE that is assessed', 'as severe will not be confused with an SAE. Severity is a category utilized for rating', 'the intensity of an event; and both AEs and SAEs can be assessed as severe.', 'An event is defined as \"serious\\' when it meets at least one of the pre-defined', 'outcomes as described in the definition of an SAE.', 'Assessment of Causality', 'The investigator is obligated to assess the relationship between study treatment and', 'the occurrence of each AE/SAE.', 'A \"reasonable possibility\" is meant to convey that there are facts/evidence or', 'arguments to suggest a causal relationship, rather than a relationship cannot be ruled', 'out.', 'The investigator will use clinical judgment to determine the relationship.', 'Alternative causes, such as natural history of the underlying diseases, concomitant', 'therapy, other risk factors, and the temporal relationship of the event to the study', 'treatment will be considered and investigated.', 'The investigator will also consult the Investigator Brochure (IB) and/or Product', 'Information, for marketed products, in the determination of his/her assessment.', 'For each AE/SAE the investigator must document in the medical notes that he/she', 'has reviewed the AE/SAE and has provided an assessment of causality.', 'There may be situations when an SAE has occurred and the investigator has minimal', 'information to include in the initial report to GSK. However, it is very important', 'that the investigator always make an assessment of causality for every event', 'prior to the initial transmission of the SAE data to GSK.', 'The investigator may change his/her opinion of causality in light of follow-up', 'information, amending the SAE data collection tool accordingly.', 'The causality assessment is one of the criteria used when determining regulatory', 'reporting requirements.', 'Follow-up of AEs and SAEs', 'The investigator is obligated to perform or arrange for the conduct of supplemental', 'measurements and/or evaluations as may be indicated or as requested by GSK to', 'elucidate as fully as possible the nature and/or causality of the AE or SAE.', 'The investigator is obligated to assist. This may include additional laboratory tests', 'or investigations, histopathological examinations or consultation with other health', '80']['2016N277425_00', 'CONFIDENTIAL', '2018N377698_00', '201749', 'care professionals.', 'If a subject dies during participation in the study or during a recognized follow-up', 'period, the investigator will provide GSK with a copy of any post-mortem findings,', 'including histopathology.', 'New or updated information will be recorded in the originally completed CRF.', 'The investigator will submit any updated SAE data to GSK within the designated', 'reporting time frames.', '12.4.6.', 'Reporting of SAEs to GSK', 'SAE reporting to GSK via electronic data collection tool', 'Primary mechanism for reporting SAEs to GSK will be the electronic data collection', 'tool', 'If the electronic system is unavailable for greater than 24 hours, the site will use the', 'paper SAE data collection tool and fax it to the Medical Monitor', 'Site will enter the serious adverse event data into the electronic system as soon as it', 'becomes available.', 'The investigator will be required to confirm review of the SAE causality by ticking', 'the \"reviewed\\' box at the bottom of the eCRF page within 72 hours of submission of', 'the SAE.', 'After the study is completed at a given site, the electronic data collection tool (e.g.,', 'InForm system) will be taken off-line to prevent the entry of new data or changes to', 'existing data', 'If a site receives a report of a new SAE from a study subject or receives updated data', 'on a previously reported SAE after the electronic data collection tool has been taken', 'off-line, the site can report this information on a paper SAE form or to the Medical', 'Monitor by telephone.', 'Contacts for SAE receipt can be found at the beginning of this protocol on the', 'Sponsor/Medical Monitor Contact Information page.', '81']\n\n###\n\n", "completion": "END"}